Sunshine may be problem for CME

The proposed rule for the Physician Payment Sunshine Act is a crucial step toward illuminating physician-industry financial ties. But patient advocacy groups and professional medical associations producing CME, though they may not be “covered recipients” under the law, could be impacted, observes Tom Sullivan, president of Rockpointe.

If such groups get a reportable payment from a manufacturer and use any portion of it or transfer of value toward a covered recipient—a physician or teaching hospital—if “the applicable manufacturer is ‘aware' of the covered recipient's identity, the manufacturer is required to report how much your organization or group…paid.”
You must be a registered member of MMM to post a comment.
close

Next Article in Features


Email Newsletters


Specialty medicines continue to be a hot category, one in which spending has surged behind products that treat medicine's most complex diseases. This eBook lays out the needs and hurdles along the specialty drug pathway, explaining how stakeholders are working to get meds into patients' hands and ease their experience. Click here to download.